Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V} -- Ignore unavailable to you. Want to Upgrade?

To: BRAVEHEART who wrote (365)	6/14/2000 5:33:00 PM
From: tuck	Read Replies (2) \| Respond to of 423

Jeffrey, Thanks for the heads up on LOR. OPTO might bear watching if insiders do something obvious. I have noticed Mr. Rosenwald of Paramount fame has filed in early June concerning purchases in some his old friends. He didn't sell much on the spike -- probably too fast for a holder of his size -- but accumulates on the dips. Or maybe offshore shorting at end of spike. Whatever. Recent buys include GNT (ex UROG, which I traded recently), NTEC, RGEN, CYPB (high 1s to low 2s), CTIC, GNTA, & ARDM. Many of these are trading very near the cost basis of these guys. I'm thinking CYPB is executing, and their market is looking better with HCFA approval. But good enough? I don't know. Any bets I take with it will be small. GNT still looks interesting on pullbacks. GNT could be due for some achievement of milestones this coming year, and that probably accounts for their interest. They seem to be buying up the float there and in DOR, too. These remain on my watch list, should the market tank soon, these possible bargains could become screaming buys. MFNX short/hedge off to a reasonable start. Cheers, Tuck